The quality of safety reporting in trials is still suboptimal: Survey of major general medical journals

Journal of Clinical Epidemiology

Volumn 64, Issue 2, 2011, Pages 124-135

  Haidich, Anna Bettina ^a   Birtsou, Charis ^a   Dardavessis, Theodore ^a   Tirodimos, Ilias ^a   Arvanitidou, Malamatenia ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Adverse events; CONSORT statement; Drugs; Harms; Quality; Randomized controlled trials

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; HORMONE; IMMUNOSUPPRESSIVE AGENT;

CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; MEDICAL LITERATURE; MEDLINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW;

GUIDELINE ADHERENCE; HUMANS; PHARMACEUTICAL PREPARATIONS; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78650517607     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2010.03.005     Document Type: Review

References (28)

1. CONSORT Web site Available at http://www.consort-statement.org Accessed December 10, 2009
2. C.B. Begg, M.K. Cho, S. Eastwood, R. Horton, D. Moher, and I. Olkin Improving the quality of reporting of randomized controlled trials: the CONSORT statement JAMA 276 1996 637 639
3. D.G. Altman, K.F. Schulz, D. Moher, M. Egger, F. Davidoff, and D. Elbourne The revised CONSORT statement for reporting randomized trials: explanation and elaboration Ann Intern Med 134 2001 663 694 (Pubitemid 32322245)
4. J.P. Ioannidis, and D.G. Contopoulos-Ioannidis Reporting of safety data from randomised trials Lancet 352 1998 1752 1753
5. J.P. Ioannidis, and J. Lau Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas JAMA 285 2001 437 443
6. J.P. Ioannidis, and J. Lau Improving safety reporting from randomized trials Drug Saf 25 2002 77 84
7. J.C. Mucklow Reporting drug safety in clinical trials: getting the emphasis right Lancet 357 2001 1384
8. J.P. Ioannidis, S.J. Evans, P.C. Gøtzche, R.T. O'Neill, D.G. Altman, and K. Schulz Better reporting of harms in randomized trials: an extension of the CONSORT statement Ann Intern Med 141 2004 781 788
9. D. Moher, A. Jones, and L. Lepage Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation JAMA 285 2001 1992 1995
10. M. Egger, P. Jüni, and C. Bartlett Value of flow diagrams in reports of randomized controlled trials JAMA 285 2001 1996 1999
11. P.J. Devereux, B.J. Manns, W.A. Ghali, H. Quan, and G.H. Guyatt The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to Consolidated Standards of Reporting Trials (CONSORT) checklist Control Clin Trials 23 2002 380 388
12. E.J. Mills, P. Wu, J. Gagnier, and P.J. Devereaux The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement Contemp Clin Trials 26 2005 480 487
13. A.C. Plint, D. Moher, A. Morrison, K. Schulz, D.G. Altman, and C. Hill Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review Med J Aust 185 2006 263 267
14. R.L. Kane, J. Wang, and J. Garrard Reporting in randomized clinical trials improved after adoption of the CONSORT statement J Clin Epidemiol 60 2007 241
15. O. Berwanger, R.A. Ribeiro, A. Finkelztejn, M. Watanabe, E.A. Suzumura, and B.B. Duncan The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals J Clin Epidemiol 62 2009 387 392
16. I. Pitrou, I. Boutron, N. Ahmad, and P. Ravaud Reporting of safety results in published reports of randomized controlled trials Arch Intern Med 169 2009 1756 1761
17. G.N. Papanikolaou, M.S. Baltogianni, D.G. Contopoulos-Ioannidis, A.-B. Haidich, I.A. Giannakakis, and J.P.A. Ioannidis Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions BMC Med Res Methodol 1 2001 3
18. R.G. Newcombe Interval estimation for the difference between independent proportions: comparison of eleven methods Stat Med 17 1998 873 890
19. E.B. Wilson Probable inference, the law of succession, and statistical inference J Am Stat Assoc 22 1927 209 212
20. S.F. Assmann, S.J. Pocock, L.E. Enos, and L.E. Kasten Subgroup analysis and other (mis)uses of baseline data in clinical trials Lancet 355 2000 1064 1069
21. R. Wang, S.W. Lagakos, J.H. Ware, D.J. Hunter, and J.M. Drazen Statistics in medicine-reporting of subgroup analyses in clinical trials N Engl J Med 357 2007 2189 2194
22. J.P. Ioannidis Adverse events in randomized trials: neglected, restricted, distorted and silenced Arch Intern Med 169 2009 1737 1738
23. D.L. Schriger, S. Ouk, and D.G. Altman The use of the World Wide Web by medical journals in 2003 and 2005: an observational study Pediatrics 119 2007 e53 e60
24. E. Evangelou, T.A. Trikalinos, and J.P. Ioannidis Unavailability of online supplementary scientific information from articles published in major journals FASEB J 19 2005 1943 1944
25. A.J. Wood Progress and deficiencies in the registration of clinical trials N Engl J Med 360 2009 824 830
26. D.G. Altman Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors BMJ 330 2005 1056 1057
27. S. Hopewell, D.G. Altman, D. Moher, and K.F. Schulz Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors' Trials 9 2008 20
28. S. Mathieu, I. Boutron, D. Moher, D.G. Altman, and P. Ravaud Comparison of registered and published primary outcomes in randomized controlled trials JAMA 302 2009 977 984